Role of the Serrated Pathway in Colorectal Cancer Pathogenesis
- 31 May 2010
- journal article
- portrait
- Published by Elsevier BV in Gastroenterology
- Vol. 138 (6), 2088-2100
- https://doi.org/10.1053/j.gastro.2009.12.066
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- A Prospective Cohort Study Shows Unique Epigenetic, Genetic, and Prognostic Features of Synchronous Colorectal CancersGastroenterology, 2009
- Sensitive digital quantification of DNA methylation in clinical samplesNature Biotechnology, 2009
- The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shoresNature Genetics, 2009
- The MLH1 −93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancerGenes, Chromosomes and Cancer, 2008
- Mutations in Both KRAS and BRAF May Contribute to the Methylator Phenotype in Colon CancerGastroenterology, 2008
- Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses β-catenin-dependent transcriptionOncogene, 2008
- Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7Cell, 2008
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- RAF/RAS oncogenes and mismatch-repair statusNature, 2002
- Mutations of the BRAF gene in human cancerNature, 2002